Company Details
|
|
Address
|
22 Melton Street, London, NW1 2BW
|
|
Telephone
|
|
|
Fax
|
|
Executives
|
|
Chairman
|
Howard Marshall (1.10% holding)
|
|
Chief Executive
|
Mark Turrell* (62.30% holding)
|
|
Finance Director
|
Shawn Taylor (0.90% holding)
|
|
Chief Technology Off.
|
Andrew Wainwright (1.20% holding)
|
Main Shareholders
|
|
|
Artemis: 6.9% Pfizer: 6.5%
|
Advisers
|
|
Nominated Adviser
|
WH Ireland
|
|
Nominated Broker
|
WH Ireland
|
|
Solicitors
|
Marriott Harrison
|
|
Auditors
|
Tenon Corporate Finance
|
|
Registrar
|
Neville Registrars
|
|
Commentary
|
|
Provider of innovation and collaborative problem solving software and process
|
Company Data |
| Code |
IMTK |
| Sedol |
GB00B1G2HX |
| Shares In Issue |
125.828 m |
| Indices
|
Aim |
| Entry on AIM |
15/12/2006 |
| Interim Results |
Nov |
| Final Results |
Jun |
| Year End |
Mar |
| Accounts Due |
Jun |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
Yes |
| |
|
|